Fig. 2From: Candidate 3-benzazepine-1-ol type GluN2B receptor radioligands (11C-NR2B-Me enantiomers) have high binding in cerebellum but not to σ1 receptorsWhole brain time-activity curves for 11C-(−)-NR2B-Me (A) and 11C-(+)-NR2B-Me (B) with different displacement doses of the GluN2B ligand Ro-25-6981 at 10 min after radioligand injection. Displacement by 0.25 mg/kg of Ro-25-6981 at 90 min for panel A was 63%, whereas that for panel B was 46%. Data are for n = 1Back to article page